Chimovits Erez
- SEC CIK
- 0001706399
No open-market purchases or sales filed in the past year.
Current role at each company
- BRVE Braveheart Bio, Inc.Director, 10% Owneras of Aug 11, 2026
- UPB Upstream Bio, Inc.Directoras of Jun 11, 2026
- HLSQ Tessera Defense & Homeland Security Inc.10% Owneras of May 20, 2024
- ACET Adicet Bio, Inc.Director, 10% Owneras of Jun 29, 2023
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Chimovits Erez as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
BRVE Braveheart Bio, Inc.
Director, 10% Owner1 trade
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Aug 11, 2026 (view filing)5:31 PM ET | Aug 7 | 4 days | Chimovits ErezDirector, 10% Owner | PPurchase | +1.94M | $18.00 | +$34.9M | New position273.3K after | 2 lotsDuplicate filing |
UPB Upstream Bio, Inc.
Director1 trade
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Oct 17, 2024 (view filing) | Oct 15 | 2 days | Chimovits ErezDirector, 10% Owner | PPurchase | +825.0K | $17.00 | +$14.0M | +22.1%4.55M after | 2 lots |
HLSQ Tessera Defense & Homeland Security Inc.
10% Owner4 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| May 20, 2024 (view filing)4:39 PM ET | May 15 | 5 daysLate | Gordon Carl L and 3 others10% Owner | SSale | −24.3K | $0.3812 | −$9.28K | −0.2%13.8M after | |
| Mar 19, 2024 (view filing)9:06 PM ET | Mar 15 | 4 days | Gordon Carl L and 3 others10% Owner | PPurchase | +6.49M | – | – | –2.16M after | Derivative2 lots |
| Mar 17, 2023 (view filing)4:29 PM ET | Feb 27 | 18 daysLate | Gordon Carl L and 3 others10% Owner | PPurchase | +348.0K | $0.245 | +$85.3K | +12.4%3.16M after | |
| Mar 17, 2023 (view filing)4:29 PM ET | Feb 27 | 18 daysLate | Gordon Carl L and 3 others10% Owner | PPurchase | +1.79M | – | – | –1.79M after | Derivative |
ACET Adicet Bio, Inc.
Director, 10% Owner1 trade
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Jun 29, 2023 (view filing)4:46 PM ET | Jun 27 | 2 days | OrbiMed Advisors LLC and 8 othersDirector, 10% Owner | PPurchase | +875.0K | $2.09 | +$1.83M | New position748.1K after | 4 lotsDuplicate filing |